{"date":"2025-04-21","count":21,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1783-2025-04-21-2133-1x4hp8r","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-04-21","time":"21:33:22","subject":"公告本公司2025年第1季合併財務報告董事會預計召開日期為2025年4月29日","clause":"第31款","fact_date":"2025-04-21","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-04-21 21:33，「公告本公司2025年第1季合併財務報告董事會預計召開日期為2025年4月29日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-04-21-1847-fp0wno","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-04-21","time":"18:47:05","subject":"公告本公司財務主管、會計主管、公司治理主管、代理發言人經董事會委任通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-04-21 18:47，「公告本公司財務主管、會計主管、公司治理主管、代理發言人經董事會委任通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-04-21-1845-bur0cv","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-04-21","time":"18:45:15","subject":"公告本公司114年第一季財務報告經審計委員會同意，並提董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-04-21 18:45，「公告本公司114年第一季財務報告經審計委員會同意，並提董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-04-21-1817-1ghkinh","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-04-21","time":"18:17:22","subject":"本公司經櫃買中心同意自114年4月22日起恢復交易","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-04-21 18:17，「本公司經櫃買中心同意自114年4月22日起恢復交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-04-21-1720-p67uuk","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-21","time":"17:20:03","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-04-21 17:20，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-04-21-1719-aik7xc","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-21","time":"17:19:12","subject":"公告本公司114年第一次現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽由特定人認購事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-04-21 17:19，「公告本公司114年第一次現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽由特定人認購事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-04-21-1718-l2zuak","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-21","time":"17:18:06","subject":"公告本公司114年度第一次現金增資股款催繳公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-04-21 17:18，「公告本公司114年度第一次現金增資股款催繳公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-04-21-1701-1fthn5r","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-04-21","time":"17:01:27","subject":"本公司114年第一次股東臨時會通過解除董事(含獨立董事)競業禁止限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-04-21 17:01，「本公司114年第一次股東臨時會通過解除董事(含獨立董事)競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-04-21-1701-55q96w","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-04-21","time":"17:01:14","subject":"公告本公司民國114年第一次股東臨時會獨立董事當選名單暨董事變動達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-04-21 17:01，「公告本公司民國114年第一次股東臨時會獨立董事當選名單暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-04-21-1700-rzgerl","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-04-21","time":"17:00:58","subject":"公告本公司成立審計委員會，監察人自然解任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-04-21 17:00，「公告本公司成立審計委員會，監察人自然解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-04-21-1700-emmmmu","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-04-21","time":"17:00:44","subject":"公告本公司成立審計委員會及第一屆審計委員名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-04-21 17:00，「公告本公司成立審計委員會及第一屆審計委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-04-21-1700-168763g","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-04-21","time":"17:00:30","subject":"公告本公司114年第1次股東臨時會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-04-21 17:00，「公告本公司114年第1次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-04-21-1649-16ikhzu","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-04-21","time":"16:49:52","subject":"公告本公司舉辦114年第一次線上法說會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-04-21 16:49，「公告本公司舉辦114年第一次線上法說會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-04-21-1625-m5scxa","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-04-21","time":"16:25:41","subject":"公告本公司董事會通過與美國大學University of NorthCarolina簽訂「T細胞強化技術」的獨家授權合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-04-21 16:25，「公告本公司董事會通過與美國大學University of NorthCarolina簽訂「T細胞強化技術」的獨家授權合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-04-21-1624-1atlj5h","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-04-21","time":"16:24:29","subject":"公告本公司董事會決議不繼續辦理113年股東常會通過之私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-04-21 16:24，「公告本公司董事會決議不繼續辦理113年股東常會通過之私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-04-21-1604-10yb8rh","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-04-21","time":"16:04:05","subject":"本公司受邀參加元富證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-04-21 16:04，「本公司受邀參加元富證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-04-21-1600-23ujga","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-04-21","time":"16:00:09","subject":"公告本公司董事會決議召開114年股東常會(新增報告及討論事項)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-04-21 16:00，「公告本公司董事會決議召開114年股東常會(新增報告及討論事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-04-21-1556-1rfb93o","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-04-21","time":"15:56:48","subject":"公告本公司召開重大訊息記者會及新聞稿內容","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-04-21 15:56，「公告本公司召開重大訊息記者會及新聞稿內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-04-21-1548-dch306","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-04-21","time":"15:48:05","subject":"本公司董事會決議通過與杜康藥業股份有限公司合併案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-04-21 15:48，「本公司董事會決議通過與杜康藥業股份有限公司合併案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2025-04-21-1530-10yb8rh","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2025-04-21","time":"15:30:39","subject":"本公司受邀參加元富證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-04-24","cite_as":"公開資訊觀測站重大訊息：生達（1720），2025-04-21 15:30，「本公司受邀參加元富證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-04-21-1406-lebi8d","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-04-21","time":"14:06:42","subject":"公告本公司召開重大訊息說明記者會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-04-21 14:06，「公告本公司召開重大訊息說明記者會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}